240 related articles for article (PubMed ID: 19706669)
1. The safety of highly active antiretroviral therapy for the HIV-positive pregnant mother and her baby: is 'the more the merrier'?
Martin F; Taylor GP
J Antimicrob Chemother; 2009 Nov; 64(5):895-900. PubMed ID: 19706669
[TBL] [Abstract][Full Text] [Related]
2. Current treatment strategies, complications and considerations for the use of HIV antiretroviral therapy during pregnancy.
Senise JF; Castelo A; Martínez M
AIDS Rev; 2011; 13(4):198-213. PubMed ID: 21975356
[TBL] [Abstract][Full Text] [Related]
3. Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis.
Kourtis AP; Schmid CH; Jamieson DJ; Lau J
AIDS; 2007 Mar; 21(5):607-15. PubMed ID: 17314523
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of HIV-infected pregnant women: prevention of virus transmission and adverse effects in mother and child].
Boer K; Nellen JF; Kreyenbroek ME; Godfried MH
Ned Tijdschr Geneeskd; 2009; 153():B410. PubMed ID: 19785876
[TBL] [Abstract][Full Text] [Related]
5. [Highly active antiretroviral therapy (HAART) in HIV-positive pregnant women in the Netherlands, 1997-2003: safe, effective and with few side effects].
Tempelman C; Timmermans S; Godfried MH; Dieleman JP; Boer K; van der Ende ME
Ned Tijdschr Geneeskd; 2004 Oct; 148(41):2021-5. PubMed ID: 15553999
[TBL] [Abstract][Full Text] [Related]
6. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial toxicity in HIV type-1-exposed pregnancies in the era of highly active antiretroviral therapy.
Gingelmaier A; Grubert TA; Kost BP; Setzer B; Lebrecht D; Mylonas I; Mueller-Hoecker J; Jeschke U; Hiedl S; Friese K; Walker UA
Antivir Ther; 2009; 14(3):331-8. PubMed ID: 19474467
[TBL] [Abstract][Full Text] [Related]
8. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.
Ekouevi DK; Coffie PA; Becquet R; Tonwe-Gold B; Horo A; Thiebaut R; Leroy V; Blanche S; Dabis F; Abrams EJ
AIDS; 2008 Sep; 22(14):1815-20. PubMed ID: 18753864
[TBL] [Abstract][Full Text] [Related]
9. Response to Kourtis et al. 'Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis'.
Townsend CL; Cortina-Borja M; Peckham CS; Tookey PA
AIDS; 2007 Aug; 21(13):1831-2. PubMed ID: 17690590
[No Abstract] [Full Text] [Related]
10. Increased rate of prematurity associated with antenatal antiretroviral therapy in a German/Austrian cohort of HIV-1-infected women.
Grosch-Woerner I; Puch K; Maier RF; Niehues T; Notheis G; Patel D; Casteleyn S; Feiterna-Sperling C; Groeger S; Zaknun D;
HIV Med; 2008 Jan; 9(1):6-13. PubMed ID: 18199167
[TBL] [Abstract][Full Text] [Related]
11. Increased rates of preterm delivery are associated with the initiation of highly active antiretrovial therapy during pregnancy: a single-center cohort study.
Martin F; Taylor GP
J Infect Dis; 2007 Aug; 196(4):558-61. PubMed ID: 17624841
[TBL] [Abstract][Full Text] [Related]
12. Maternal antiretroviral drugs during pregnancy and infant low birth weight and preterm birth.
Szyld EG; Warley EM; Freimanis L; Gonin R; Cahn PE; Calvet GA; Duarte G; Melo VH; Read JS;
AIDS; 2006 Nov; 20(18):2345-53. PubMed ID: 17117021
[TBL] [Abstract][Full Text] [Related]
13. Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort.
Warszawski J; Tubiana R; Le Chenadec J; Blanche S; Teglas JP; Dollfus C; Faye A; Burgard M; Rouzioux C; Mandelbrot L;
AIDS; 2008 Jan; 22(2):289-99. PubMed ID: 18097232
[TBL] [Abstract][Full Text] [Related]
14. Maternal antiretrovirals and hepatic enzyme, hematologic abnormalities among human immunodeficiency virus type 1-uninfected infants: the NISDI perinatal study.
Mussi-Pinhata MM; Rego MA; Freimanis L; Kakehasi FM; Machado DM; Cardoso EM; Read JS;
Pediatr Infect Dis J; 2007 Nov; 26(11):1032-7. PubMed ID: 17984811
[TBL] [Abstract][Full Text] [Related]
15. Obstetric and perinatal complications in HIV-infected women. Analysis of a cohort of 167 pregnancies between 1997 and 2003.
Martí C; Peña JM; Bates I; Madero R; de José I; Pallardo LF; Arribas JR; Gonzalez-Garcia J; Gonzalez A; Vazquez JJ
Acta Obstet Gynecol Scand; 2007; 86(4):409-15. PubMed ID: 17486461
[TBL] [Abstract][Full Text] [Related]
16. Hyperlactatemia in human immunodeficiency virus-uninfected infants who are exposed to antiretrovirals.
Noguera A; Fortuny C; Muñoz-Almagro C; Sanchez E; Vilaseca MA; Artuch R; Pou J; Jimenez R
Pediatrics; 2004 Nov; 114(5):e598-603. PubMed ID: 15492359
[TBL] [Abstract][Full Text] [Related]
17. [HIV and pregnancy].
Petry KU
MMW Fortschr Med; 2005 Apr; 147 Spec No 1():63-5. PubMed ID: 16385880
[TBL] [Abstract][Full Text] [Related]
18. Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989-2004.
Schulte J; Dominguez K; Sukalac T; Bohannon B; Fowler MG;
Pediatrics; 2007 Apr; 119(4):e900-6. PubMed ID: 17353299
[TBL] [Abstract][Full Text] [Related]
19. Perinatal outcomes, mitochondrial toxicity and apoptosis in HIV-treated pregnant women and in-utero-exposed newborn.
Hernàndez S; Morén C; López M; Coll O; Cardellach F; Gratacós E; Miró O; Garrabou G
AIDS; 2012 Feb; 26(4):419-28. PubMed ID: 22156962
[TBL] [Abstract][Full Text] [Related]
20. Serious toxicity associated with continuous nevirapine-based HAART in pregnancy.
van Schalkwyk JE; Alimenti A; Khoo D; Maan E; Forbes JC; Burdge DR; Gilgoff S; Money DM
BJOG; 2008 Sep; 115(10):1297-302. PubMed ID: 18715416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
